**Core Concept**
Fluoroquinolones are a class of broad-spectrum antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death. The withdrawal of certain fluoroquinolones has been attributed to their adverse effects and resistance patterns.

**Why the Correct Answer is Right**
Gemifloxacin is a fourth-generation fluoroquinolone that has been retained in the market due to its favorable pharmacokinetic and pharmacodynamic properties. Unlike other fluoroquinolones, Gemifloxacin has a lower potential for QT interval prolongation and gastrointestinal side effects, making it a safer option for patients. Its mechanism of action involves the inhibition of DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and transcription.

**Why Each Wrong Option is Incorrect**
**Option A:** Trovafloxacin was withdrawn from the market due to its potential for liver toxicity and QT interval prolongation. Its use was also associated with an increased risk of Stevens-Johnson syndrome and toxic epidermal necrolysis.

**Option B:** Gatifloxacin was withdrawn in several countries due to reports of hypoglycemia and hyperglycemia, as well as its potential to prolong QT intervals. Its use was also associated with an increased risk of Clostridioides difficile infection.

**Option D:** Grepafloxacin was withdrawn from the market due to its potential for QT interval prolongation and torsades de pointes. Its use was also associated with an increased risk of liver toxicity and gastrointestinal side effects.

**Clinical Pearl / High-Yield Fact**
Gemifloxacin's retention in the market highlights the importance of pharmacokinetic and pharmacodynamic properties in determining the safety and efficacy of antibiotics. Clinicians should be aware of the potential for adverse effects and resistance patterns when prescribing fluoroquinolones.

**Correct Answer:**
✓ Correct Answer: C. Gemifloxacin